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The proton-pumping NADH:ubiquinone oxidoreductase, also called complex I, is the entry point for electrons into the respiratory chains
of many bacteria and mitochondria of most eucaryotes. It couples electron transfer with the translocation of protons across the membrane,
thus providing the proton motive force essential for energy-consuming processes. Electron microscopy revealed the ‘L’-shaped structure of
the bacterial and mitochondrial complex with two arms arranged perpendicular to each other. Recently, we showed that the Escherichia coli
complex I takes on another stable conformation with the two arms arranged side by side resulting in a horseshoe-shaped structure. This model
reflects the evolution of complex I from pre-existing modules for electron transfer and proton translocation.
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evolution1. Introduction
The inner membrane of mitochondria and the cytoplas-
mic membrane of bacteria contain a proton-pumping
NADH:ubiquinone oxidoreductase, which is also called
respiratory complex I. Complex I is a multisubunit complex
catalyzing the electron transfer from NADH to quinone
coupled with the translocation of four protons across the
membrane according to the equation:
NADHþ Qþ 5Hþn ! NADþ þ QH2 þ 4Hþp
where Q refers to quinone, and Hn
+ and Hp
+ to the protons
taken up from the negative inner side and delivered to the
positive outer side of the membrane [1–4]. In doing so, it
contributes to the proton motive force required for energy-
consuming processes. More recently, it has been demon-
strated that in Klebsiella pneumoniae the complex trans-
locates sodium ions instead of protons [5] and thus0005-2728/$ - see front matter D 2003 Elsevier B.V. All rights reserved.
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Abbreviations: Complex I, proton-translocating NADH:ubiquinone
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mononucleotide
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I exist in the cyanobacteria, chloroplasts and archaea [6,7].
Characteristic features of complex I are its large number of
subunits, its multiple prosthetic groups, namely one flavin
mononucleotide (FMN) and up to nine iron–sulfur (Fe/S)
clusters, and its sensitivity to a great variety of naturally
occurring or synthetic inhibitors [8,9].
Due to its complex composition and the lack of high-
resolution structural data, little is known about the mecha-
nism of this large enzyme complex. However, it would be
highly desirable to obtain more knowledge about the way
complex I works in order to understand the molecular basis
of a surely unique proton pump. In addition, it is now well-
established that isolated complex I deficiencies are the most
frequently encountered disturbances of the mitochondrial
oxidative phosphorylation [10,11]. Finally, complex I is of
industrial interest as a possible target for insecticides or
acaricides [12,13].
This review will deal with the gross structure of complex I
as revealed by electron microscopy. During the past years
two-dimensional (2D) projection maps and three-dimension-
al (3D) structures of complex I from Neurospora crassa [14],
Escherichia coli [15–17], Bos taurus [18,19], Yarrowia
lipolytica [20,21], and Aquifex aeolicus [22] have been
resolved at low resolution (17–34 A˚). From the models
derived by means of electron microscopy it is generally
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arms standing perpendicular to each other (for review see
Ref. [23]). Recently, we have proposed that the E. coli
complex I is capable of adopting another conformation with
the two arms arranged side by side [17]. The significance of
this observation as well as the modular structure of complex I
will be discussed in this review.2. Composition of complex I
The simplest form of a proton-pumping NADH:ubiqui-
none oxidoreductase known so far exists in bacteria [4–
7,24]. In general, the bacterial complex consists of 14
different subunits, which add up to a molecular mass of
about 535 kDa [25–28]. Homologues of these 14 subunits
are part of complex I in all species known so far (Table 1).
Therefore, it is suspected that they build the catalytic core of
complex I and are called ‘minimal’ subunits [2,6]. The 14
different subunits are designated either as NuoA to NuoN or
Nqo1 to Nqo14 in bacteria and can be classified in two
groups (Table 1): seven subunits (NuoB–G and NuoI) are
peripheral proteins including the subunits that bear all
known redox groups of complex I. In addition, NuoF
contains the NADH binding site [29] and NuoB and D are
probably involved in quinone binding (Table 1) [30–32].
The remaining seven subunits (NuoA, H, and NuoJ–N) are
mostly hydrophobic proteins predicted of folding into 54 a-
helices across the membrane [6,7,24]. These subunits do not
contain typical cofactor-binding motives and consequently
no redox groups have been detected up to now. NuoH, L,
and M are suspected of being involved in quinone bindingTable 1
Nomenclature, localization and properties of the 14 ‘minimal’ complex I
subunits
Designation of subunit
(Bacteria/Eucarya)
Localization Predicted function
NuoA/ND3 membrane arm ?
NuoB/PSST peripheral arm [4Fe–4S];
N2 ubiquinone-binding?
NuoC/30 kDa (IP)a peripheral arm ?
NuoD/49 kDa (IP)a peripheral arm Ubiquinone binding?
NuoE/24 kDa (FP) peripheral arm [2Fe–2S]; N1a
NuoF/51 kDa (FP) peripheral arm NADH- and FMN-binding
[4Fe–4S]; N3
NuoG/75 kDa (IP) peripheral arm 3 [4Fe–4S]; N1cb, N4,
N5 [2Fe–2S], N1b
NuoH/ND1 membrane arm Ubiquinone binding?
NuoI/TYKY peripheral arm 2 [4Fe–4S]; N6a, N6b
NuoJ/ND6 membrane arm ?
NuoK/ND4L membrane arm Proton translocation?
NuoL/ND5 membrane arm Ubiquinone binding?
Proton translocation?
NuoM/ND4 membrane arm Ubiquinone binding?
Proton translocation?
NuoN/ND2 membrane arm Proton translocation?
a NuoC and D are fused in some bacteria.
b This cluster is only present in some bacteria.[33–35]. As only the seven hydrophobic subunits are
predicted of containing membrane-spanning helices, they
are most likely also involved in proton translocation. This is
supported by the fact that NuoL, M, N, and most likely
NuoK are homologues to a distinct class of Na+ (or K+)/H+
antiporter and are likely to contain H+-pathways [7,24,
36,37]. However, this assumption still awaits experimental
verification.
In addition to the homologues of the 14 subunits present
in bacteria, the mitochondrial complex I of eucaryotes
contains at least 32 extra subunits resulting in a molecular
mass of approximately 1 MDa [1,2,38]. The homologues of
the seven hydrophobic subunits are mitochondrially encoded
in eucaryotes. The extra subunits known so far are all
encoded by nuclear genes [39]. Although their function is
not clear, they probably form an insulation around complex I
preventing the high energy electrons from escaping or they
are needed to regulate the assembly of the complex [39].
However, at least four extra subunits seem to have a function
specific for mitochondria: a 10 kDa subunit was found to be
an acyl carrier protein with a phosphopantetheine as pros-
thetic group [40,41]. A 39/40 kDa ‘‘accessory’’ subunit
contains a tightly bound NADPH and is related to short-
chain dehydrogenases/reductases [42,43]. A 16.6 kDa sub-
unit of bovine complex I was found to be GRIM-19, the
product of a cell death regulatory gene [43]. Finally, an
18 kDa subunit is phosphorylated by a cAMP-dependent
protein kinase and plays a role in the regulation of complex I
activity [44].3. The gross structure of complex I from bacteria and
eucarya
The first structural information on complex I was derived
from bovine heart complex I by means of single particle
analysis and a tilt series of 2D membrane crystals [45,46].
The results were interpreted in a model showing four
monomers arranged as a pair of dimers with a molecular
mass of 1.6 MDa [46]. Later on, it turned out that the
tetrameric crystals were composed of only a fragment of the
complex [47]. Work carried out with the complex from N.
crassa reconstituted in membranes revealed for the first time
its two partite structure [47]. However, the derived model
was not correct, due to an underestimation of the protein
mass buried in the membrane. In a subsequent publication,
the characteristic L-shape of the complex was described as
being derived from single particle analysis and 2D mem-
brane crystals [48]. One arm of the L, called the peripheral
arm, protrudes into the aqueous phase and consists of the
hydrophilic subunits. The other arm of the L, called the
membrane arm, is embedded within the lipid bilayer and is
made up of hydrophobic subunits (Fig. 1, Table 1). The two
arms were distinguished from each other by electron micro-
graphs of preparations of the individual arms of the N.
crassa complex I [48].
Fig. 1. Models of the 3D structures of complex I from E. coli [15], Y. lipolytica (M. Bostina, U. Brandt and M. Radermacher, personal communication), N.
crassa [14] and B. taurus [18] (from left to right). A side-view is shown and the scale is identical for all views. The membrane arm runs horizontally. The model
of the bovine complex I was derived by means of electron cryo-microscopy, the other models were derived from staining detergent solubilized complex I with
uranyl acetate.
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complex I was done with single particle image analysis of
negatively stained particles [14,15,17,18,21,22]. This tech-
nique has the advantage that no well-ordered 2D crystals are
needed but is susceptible to artefacts caused by uneven
staining of the particles or by flattening of the particles
during drying. The detergent bound to the protein may affect
the staining of the particle and variability of the individual
particles may lead to a loss in resolution. Electron cryo-
microscopy is often used to circumvent some of these
problems, as the structure of the particles is preserved better,
when surrounded by vitrified buffer [49]. Significant prog-
ress had been made along these lines with the bovine
complex [18]. In addition, projection maps of 2D crystals
of the bovine complex I have been obtained [19], however,
3D information on the organization of the complex within
these crystals is still missing.
The models obtained from complex I from different
sources all show the typical L-shaped structure (Fig. 1).
The position of the peripheral arm of the N. crassa complex I
was verified by immuno-labelling of the 49 kDa subunit,
which is part of the peripheral arm [14]. The peripheral and
membrane arms of the E. coli and Y. lipolytica complex I
were attributed by alignment with the model of the N. crassa
complex I [15,20]. Recently, this assignment was verified
for Y. lipolytica by localizing the 49 kDa protein at a
position comparable to the N. crassa complex [21]. The
bovine complex was orientated relative to the membrane
mainly by the mass distribution between the two arms and
the presence of a constriction in one arm of the complex,
which has also been detected in the membrane arm of the N.
crassa complex I [14,18]. The two arms of the A. aeolicus
complex have been assigned by similarity with the other
models [22]. The models show that the two arms of the
mitochondrial complex are about 23 nm and approximately
of equal length [15,18]. More surprisingly, both arms of the
bacterial complex are about 20 nm, thus being only slightly
shorter than those of the mitochondrial complex, although
the former contains only half the protein mass of the latter
[15]. Comparison of the N. crassa complex with the E. coli
complex suggests that the extra mass of the mitochondrial
complex is evenly distributed around the catalytic core
provided by the bacterial complex [15].Although all models of complex I derived by means of
electron microscopy show the same L-shaped structure,
there are differences concerning details of the models
(Fig. 1). Some of these variations may result from differ-
ences in the protein composition of the complexes, others
from differences in staining or different approaches to image
processing. A major question concerns the presence of a
stalk connecting the two arms [18]. A stalk with a diameter
of about 3 nm is present in the models of the bovine and E.
coli complex I [15,18] but not in those of the N. crassa and
Y. lipolytica enzyme ([14,48], M. Bostina, U. Brandt and M.
Radermacher, personal communication). From a compari-
son of 3D maps of the E. coli and the N. crassa complex,
Gue´nebaut et al. [15] concluded that in N. crassa, the stalk
region might be filled with at least two additional subunits,
which form a 50 kDa domain. This would lead to the
conclusion that the stalk region is a genuine feature of the
bacterial complex, which is filled by additional subunits in
the mitochondrial complex I. However, the stalk may not be
as thin as shown in Ref. [15] due to stain penetration. The
bovine complex, which also has a stalk [18], does not fit
into this picture. However, it is possible that some of the
additional subunits in the stalk region are only loosely
attached and could be lost or displaced during purification
and concentration. On the other hand, it cannot be excluded
that the stalk may represent a constriction in the membrane
arm due to a wrong assignment of the arms in the 3D model.
Another difference concerns the angle between the two
arms. A fixed angle of about 90j has been reported for the
N. crassa, B. taurus and A. aeolicus complex [18,22,48],
while this angle seems to be variable in the E. coli and Y.
lipolytica complex ([15]; U. Brandt, personal communica-
tion). Values between 0j for the E. coli complex [17] and up
to 180j for the Y. lipolytica complex (M. Bostina, U. Brandt
and M. Radermacher, personal communication) have been
reported. It is not known whether this has any significance
for the mechanism of the complex (see below).4. The alternative conformation of the E. coli complex I
The L-shaped structure of complex I is generally accept-
ed [1–4]. However, the electron transport chain is spatially
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The electron transfer from NADH to ubiquinone takes place
solely in the peripheral arm, which comprises the binding
sites for NADH, FMN and all FeS clusters [15]. Even the
quinone-binding site is thought to be located in the connec-
tion between the peripheral and the membrane arm, because
it is made up of hydrophilic as well as hydrophobic subunits
[3,6,24,33,50].
The membrane arm, constituting approximately half of
the protein mass, is involved in quinone binding and in
proton translocation (Table 1; [24,32–36,51]). Mutations in
all subunits of the membrane arm reduce the electron
transport activity of complex I ([52,53], http://www.mito-
map.org.) leading to the conclusion that proton translocation
in the membrane arm must be coupled with the electron
transfer in the peripheral arm. The spatial separation of the
coupled events of electron transport and proton transport led
many groups to the proposal of an indirect mechanism of
proton pumping which is driven by conformational changes
[54–56]. This proposal is supported by several experiments:
(1) the labelling pattern of complex I by either photoaffinity
inhibitors or cross-linkers depends on the redox state of the
complex [57–59]. (2) Amiloride-type inhibitors, which
were originally described as inhibitors of Na+/H+ antiport-
ers, are found to act specifically on complex I [33,60,61]. As
it is thought that antiporters operate by conformational
changes, a similar mechanism is anticipated for complex I
[55]. (3) It is supposed that that the subunits NuoL and M
which are most likely involved in proton translocation are
located at the distal end of the membrane arm spatially
separated from the redox groups in the peripheral arm
[19,62]. (4) FT-IR spectroscopy has directly shown that
the redox reaction of complex I is accompanied by large
protein rearrangements [63–65].
A mechanism of complex I including conformational
changes was also supported by the finding that the K.Fig. 2. Cartoon of complex I, showing the three modules. The NADH
dehydrogenase module is drawn in yellow, the hydrogenase module in red
and the transporter module in blue. The Fe/S clusters are denoted as N1a,
N1b, N2, N3, N4, N5, N6a, and N6b. The two proposed coupling sites are
indicated, see text for details.pneumoniae complex I translocates sodium ions instead of
protons [5]. The translocation of sodium ions can hardly be
imagined by a direct pumping mechanism. However, it was
also reported that this enzyme works with a stoichiometry of
2 Na+ per 2 e [5], while 4 H+ per 2 e have been
determined for the proton translocating complex I from
bacteria and mitochondria [66–71]. The high sequence
identity between the proton pumping E. coli complex I
[69,71] and the sodium pumping K. pneumoniae complex I
[5] makes it unlikely that they operate with completely
different mechanisms. It was suggested that complex I
contains two coupling sites, one employing direct redox
coupling with the Fe/S cluster N2 and the other involving an
indirect, conformationally linked type of mechanism (Fig. 2;
[54]). This assumption agrees well with the hypothesis that
complex I evolved from pre-existing blocks for electron
transport and proton translocation ([7,24,36,37]; and see
below). The lower ion per electron stoichiometry of the
sodium pumping enzyme may be due to the activity of only
the conformationally linked coupling site.
A conformationally coupled mechanism of complex I
implies a major movement of the protein as demonstrated
for the F-type ATP-synthases or P-type-ATPases. Thus, one
would expect at least two different conformations of com-
plex I. Recently, we demonstrated that in E. coli, the L-
shaped conformation is only one of at least two stable
conformations of the isolated complex [17]. In the other
conformation, the peripheral and the membrane arm are
arranged parallel to each other (Fig. 3). In vitro, the
transition between the two conformations is induced by
the ionic strength of the buffer and is completely reversible.
At high ionic strength, the L-shaped conformation is ob-
served. At low ionic strength, the complex takes an alter-
native conformation with both arms arranged side by side as
in a horseshoe [17]. It is noteworthy that the conformational
change is apparently due to a movement of the electron
input module of the complex. In the L-shaped conformation,
this module is buried within the peripheral arm and it is
opened out in the horseshoe-shaped conformation represent-
ing a separate peripheral domain. In the horseshoe-shaped
conformation, each of the two arms is formed by two
distinct domains (Fig. 3). Annotation of the two arms of
the complex was made by comparison with a fragment of
the complex lacking the peripheral electron input module
(Fig. 3; [6,7,17]). This approach identified one of the two
peripheral domains as the electron input module. We pro-
pose that the individual domains display the different
modules from which complex I emerged during evolution
(see below).
Our studies have recently been challenged by a report by
Sazanov et al. [16] demonstrating that the isolated E. coli
complex I is in the L-shaped conformation in 2D crystals
and that this conformation is enzymatically active. The
horseshoe-shaped conformation was not detected in this
study. The differences between this and our study seem to
be due to the different purification protocols resulting in
Fig. 3. Model of E. coli complex I conformations in a buffer of high (A) and
low (B) ionic strength. The first and the second row show orthogonal views
of surface representations parallel to the plane of the membrane. The third
row views normal to the plane of the membrane. The bilayer is symbolized
by the grey shaded area. The NADH dehydrogenase module is drawn in
yellow, the hydrogenase module in red and the transporter module in blue.
The scale is given.
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complex. These differences most likely concern the phos-
pholipid and quinone content of both preparations. Many
properties of membranous protein complexes are influenced
by the amount of lipid bound to the preparation [72]. Our
preparation contains 0.5 mol ubiquinone per mole of com-
plex I and approximately five lipid molecules per molecule
of complex I ([34]; T. Friedrich, unpublished data). Most
likely due to the low amount of lipids contained in the
preparation, the enzyme exhibits very little activity in
detergent solution, which is stimulated 20-fold by an addi-
tion of E. coli lipids. The preparation described by Sazanov
et al. shows four times as much activity in detergent solution
than our preparation but is only activated 3-fold by an
addition of phospholipids under comparable experimental
conditions (approximately 100 mM salt, added E. coli polar
lipids dissolved in dodecyl maltoside) [16]. Accordingly, the
lipid-stimulated activity in both preparations is comparable.
However, only the activity of our preparation is sensitive to
rotenone and piericidin A [17,71], which is indicative of a
physiological decyl–ubiquinone reduction [73,74]. Another
difference is the presence of CaCl2 in the Sazanov protocol.
Due to this, a certain amount of CaCl2 is carried over with
the protein to all assays. It is shown that the presence of
these ions stabilizes the complex [16], probably by fixing itin a certain, i.e. L-shaped conformation. This hypothesis is
supported by the formation of 2D crystals of complex I in
the presence of CaCl2, where the conformational homoge-
neity of the complex would be beneficial.
The suggestion that the horseshoe-shaped conformation
is only a result of a dimerization of the membrane arm of the
E. coli complex I [16] can be completely ruled out for three
reasons: first, analytical ultracentrifugation has unambigu-
ously shown that our preparation has an identical molecular
mass with the same number of components in a buffer of
high and low ionic strength. Merely the sedimentation
coefficient changes from 22 S in a buffer of low ionic
strength to 15 S in a buffer of high ionic strength [17]. These
observations are consistent with a conformational change
but not with a disintegration/dimerization event. Secondly,
neither the dimer of the membrane arm nor the residual
peripheral arm show inhibitor-sensitive NADH:quinone
reductase activity which we measured for the horseshoe-
shaped conformation. Thirdly, the change from the horse-
shoe-shaped conformation to the L-shaped conformation
accompanied by a loss of activity is completely reversible.
This leaves the question: which conformation type occurs
in the lipid bilayer at more physiological salt concentra-
tions? Information on this issue comes from the analysis of
complex I reconstituted in a membrane in 2D crystals.
Different groups have reported side-view projections at the
edge of the complex which are consistent with the L-shape
[16,48]. Unfortunately, the length of the peripheral arm of
the complex protruding from the lipid bilayer in side-views
of the 2D crystals is an ambiguous criterion to distinguish
between the L- or the horseshoe-shaped conformation as the
difference in height is only minor [17] and insignificant at
the given uncertainty of orientation. Conclusions on the
conformational state of the complex were also drawn from
2D projection maps of the crystals, which are in agreement
with the peripheral arm projecting out of the membrane as
expected in the L-shaped conformation. Interestingly,
depending on the crystal packing, a smaller density at the
distal end of the membrane arm was observed for the E. coli
complex, which was not present in the single molecule
representations [16]. It has been argued that this distal
density is solely caused by a different penetration of the
stain in the different crystal forms [16]. However, the
observation of the smaller density at the distal end would
also agree with a horseshoe-shaped conformation, because
the constriction in the peripheral arm would lead to two
distinct densities in projection. Of these two densities, the
distal one corresponding to a smaller mass should also be
smaller (Fig. 4, insert). Without a 3D map, it will be
impossible to decide which conformation the complex has
in this type of crystal.
We took a different approach for information on the
conformational state of the E. coli complex I in the mem-
brane. The complex was reconstituted in liposomes of E.
coli polar lipids (protein/lipid 1:4 (w/w) in 50 mM MES/
NaOH, 50 mM NaCl, pH 6.0 as described in Ref. [75]) and
Fig. 4. E. coli complex I reconstituted in phospholipids. (A) Micrograph of proteoliposomes embedded in vitrified buffer. (B) Class averages of 380 side-view
projections of complex I. Projections with the peripheral arm parallel to the surface of the liposomes as expected for the horseshoe-shaped conformation are
marked with (*), intermediate orientations are marked with (o). (C) Class averages of 260 top view projections. Some of the projections show a larger slightly
elongated density (+) as expected for L-shaped particles, others show a larger and a smaller density (#) as expected for horseshoe-shaped particles. (D)
Calculated top view projections of the L-shaped (left) and horseshoe-shaped complex (right) as published in Ref. [17]. The scale bar marks 100 A˚.
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(50 mM MES/NaOH, 50 mM NaCl, pH 6.0; Fig. 4). In
liposomes, the complex has no conformational constraints
like those caused by the packing of the protein in a 2D
crystal. Therefore, the complex can adopt any stable con-
formation. To understand the resulting projection maps,
some basic geometrical considerations have to be taken: in
general, at the edge of the liposomes, side-view projections
parallel to the plane of the membrane are observed, whereas
in the centre of the liposomes, top-view projections perpen-
dicular to the plane of membrane are found. In a first
approximation, an L-shaped particle should show only one
type of side-view projection, with the peripheral arm seen as
a rod-like feature perpendicular to the membrane. For a
horseshoe-shaped particle, a similar side-view projection is
expected although protruding slightly less. Therefore, the
observation of rod-shaped projections perpendicular to the
membrane are not evidence for the presence or absence of
an L- or horseshoe-shaped conformation. For the horseshoe-
shaped conformation, there should also be other side-view
projections where the peripheral arm is approximately
parallel to the surface of the liposome. Such side-views
were indeed observed (Fig. 4B (*)) and could not be
explained by the presence of L-shaped particles alone.
The occurrence of these particles required a conformation
in which the membrane arm is more or less parallel to the
plane of membrane as for example in the horseshoe-shaped
conformation. However, it is still impossible to distinguish
between a conformation in which the peripheral arm is
parallel to the membrane arm or in which there is an angle
close to 180j between membrane arm and peripheral arm.
In a conformationally homogeneous population, top-
view projections should all be similar and should be related
by in-plane rotation and/or mirror symmetry. We observed
not one but two types of top-views in liposomes (Fig. 4C (#)
and (+)). These projections were similar to calculatedprojections of the 3D map of the horseshoe-shaped and L-
shaped complexes (Fig. 4D; [17]). From these observations,
we conclude that the E. coli complex I reconstituted in
liposomes can adopt different conformations, which vary in
the position of the peripheral arm and are in principle
consistent with an L-shaped and a horseshoe-shaped con-
formation. From this, we propose that the peripheral arm of
the complex has some conformational flexibility and might
perform small movements similar to a handle of a pump
during catalysis. The horseshoe-shaped conformation and
the conformation with a 180j angle between the two arms
(see above) might reflect two extreme positions of this
conformational flexibility.5. The modular structure of complex I
Sequence analysis revealed that complex I evolved from
three major modules for electron transport and proton
translocation [6,7,24,36,37,54]. The soluble NADH dehy-
drogenase module represents the electron input part men-
tioned above. This module is also found in many non-
energy-converting NAD(P)H-dependent hydrogenases and
dehydrogenases and is involved in electron transfer [6,7].
The hydrogenase module is made up of hydrophilic as well
as hydrophobic subunits and is also present in a family of
membrane-bound multisubunit [NiFe] hydrogenases [76].
This module is involved in redox-coupled proton transloca-
tion [54,76]. The transporter module is entirely formed by
hydrophobic subunits, among them homologues of H+/Na+
or H+/K+ antiporter subunits [36,37,51], indicating their
possible involvement in conformational-driven ion-translo-
cation in complex I [54].
The modular evolution of the complex is reflected in its
Lego-like structure (Fig. 3B). The model of the 3D structure
of complex I at low ionic strength shows the presence of
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other [17]. The position of the NADH dehydrogenase
module is obvious from the comparison of the model of a
fragment of complex I missing this module [17]. As
depicted in Fig. 3B, it corresponds to the yellow domain
in the upper right position. This module is linked to the
hydrogenase module, thus connecting the electron transport
chain from NADH to ubiquinone [54]. The hydrogenase
module corresponds to the two domains on the left side of
the model drawn in red in Fig. 3B. The upper domain
corresponds to the hydrophilic subunits of this module,
while the lower one is made up of the hydrophobic subunits.
The transporter module is attached to the membranous
domain of the hydrogenase module. The connection be-
tween these two hydrophobic domains is visible as a
constriction detected in the membrane arm of the N. crassa
and the bovine complex I [18,19,48]. In the horseshoe-
shaped conformation derived from negatively stained single
particles, the transporter module seems to have contact with
the NADH dehydrogenase module (Fig. 3B). The modular
evolution of complex I was first recognized from the
conserved gene order of the complex I genes in bacteria
and the homology of these genes to other genes coding for
different enzymes [6]. Now, the modular evolution of the
complex is seen in its modular overall structure as well. The
modules with different functions for electron transfer and
proton translocation were combined during evolution like
bricks from a Lego System.Acknowledgements
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